Literature DB >> 27069136

Implications of Differential Expression of β-Catenin in Oral Carcinoma.

Miguel Angel Gonzalez Moles1, José Antonio Gil Montoya2, Maria Dolores Martín Salvago3, Isabel Ruiz Ávila4, Juan José Plaza Campillo2, Manuel Bravo2.   

Abstract

BACKGROUND: Alterations of β-catenin can promote cancer progression, but there has been little analysis of this protein in oral squamous cell carcinoma (OSCC). The objective of this study was to investigate the role of β-catenin in OSCC development.
MATERIALS AND METHODS: Expression of β-catenin and Ki-67 from 92 OSCC was immunohistochemically studied in tissues close to the tumor invasion point and, in 37 cases, in tissues distant from the invasion point.
RESULTS: Loss of membranous β-catenin expression was observed in 77.2% of "close" samples and 94.4% of "distant" samples. Nuclear β-catenin expression was detected in 35.9% of adjacent samples and 44.4% of "distant" samples. Nuclear β-catenin expression in ≥10% of cells was observed in 6.6% of "close" samples and 25% of "distant" samples. No relationship was found between β-catenin expression and cell proliferation.
CONCLUSION: β-Catenin plays a major oncogenic role in OSCC, principally through increase in invasiveness due to loss of its membranous expression. Copyright
© 2016 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Ki-67; WNT/canonical pathway; immunohistochemistry; oral cancer; β-Catenin

Mesh:

Substances:

Year:  2016        PMID: 27069136

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Glycogen synthase kinase-3β mediated regulation of matrix metalloproteinase-9 and its involvement in oral squamous cell carcinoma progression and invasion.

Authors:  Kamdeo K Pramanik; Siddavaram Nagini; Abhay K Singh; Prajna Mishra; Tanushree Kashyap; Nidhi Nath; Manzar Alam; Ajay Rana; Rajakishore Mishra
Journal:  Cell Oncol (Dordr)       Date:  2017-11-13       Impact factor: 6.730

2.  Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.

Authors:  Meng Wang; Zhigang Feng; Xiaoxi Li; Shulan Sun; Li Lu
Journal:  Mol Cell Biochem       Date:  2021-03-01       Impact factor: 3.396

3.  Involvement of RUVBL1 in WNT/β-Catenin Signaling in Oral Squamous Cell Carcinoma.

Authors:  Yongfa Zeng; Ying Kong; Lan Liao; Hongshui Zhu
Journal:  Dis Markers       Date:  2022-04-22       Impact factor: 3.464

4.  Higher expression of WNT5A protein in oral squamous cell carcinoma compared with dysplasia and oral mucosa with a normal appearance.

Authors:  Zdenka Prgomet; Tommy Andersson; Pia Lindberg
Journal:  Eur J Oral Sci       Date:  2017-06-12       Impact factor: 2.612

Review 5.  Prognostic and Clinicopathological Significance of the Aberrant Expression of β-Catenin in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Pablo Ramos-García; Miguel Á González-Moles
Journal:  Cancers (Basel)       Date:  2022-01-18       Impact factor: 6.639

6.  Expression and Role of E-Cadherin, β-Catenin, and Vimentin in Human Papillomavirus-Positive and Human Papillomavirus-Negative Oropharyngeal Squamous Cell Carcinoma.

Authors:  Hesham Mohamed; Caj Haglund; Lauri Jouhi; Timo Atula; Jaana Hagström; Antti Mäkitie
Journal:  J Histochem Cytochem       Date:  2020-08-14       Impact factor: 2.479

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.